Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.
2018.
Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.
Berti V, Walters M, Sterling J, Quinn CG, Logue M, Andrews R, Matthews DC, Osorio RS, Pupi A, Vallabhajosula S et al..
2018.
Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults.. Neurology. 90(20):e1789-e1798.
Kang Y, P Mozley D, Verma A, Schlyer D, Henchcliffe C, Gauthier SA, Chiao PC, He B, Nikolopoulou A, Logan J et al..
2018.
Noninvasive PK11195-PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease.. J Neuroimaging. 28(5):496-505.
Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT et al..
2018.
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.. N Engl J Med. 379(9):846-855.
Pillai RLI, Malhotra A, Rupert DD, Weschler B, Williams JC, Zhang M, Yang J, J Mann J, Oquendo MA, Parsey RV et al..
2018.
Relations between cortical thickness, serotonin 1A receptor binding, and structural connectivity: A multimodal imaging study.. Hum Brain Mapp. 39(2):1043-1055.
Noch EK.
2018.
Til Neglect Do Us Part.. JAMA Neurol. 75(7):785-786.